NCT01339442View on ClinicalTrials.gov

BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 14, 2011

Primary Completion Date

December 21, 2016

Study Completion Date

December 28, 2016

Conditions

Estrogen Receptor-positive Breast CancerRecurrent Breast CancerStage IV Breast Cancer

Interventions

DRUG

BKM120

DRUG

Fulvestrant

PROCEDURE

biopsy

Correlative studies

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Washington University School of Medicine

OTHER

NCT01339442 - BKM120 and Fulvestrant for Treating Postmenopausal Patients With Estrogen Receptor-Positive Stage IV Breast Cancer | Biotech Hunter | Biotech Hunter